| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.08 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.075 | 0.08 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |